4Nomine Y, Masson M, Charbonnier S, et al. Structural and functional analysis of E6 oncoprotein:insights in the mo- lecular pathways of human papillomavirus-mediated patho- genesis [ J ]. Mol Cell, 2006,21 ( 5 ) :665-678.
5Garcia-Hemandez E, Gonzalez-Sanchez J L, Andrade-Manzano A, et al. Regression of papilloma high-grade le- sions (CIN 2 and CIN 3 ) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine [ J ]. Cancer Gene Ther, 2006,13 (6) : 592-597.
6Zhou L, Zhu T, Ye X, et al. Long-term protection against human papillomavirus e7-positive tumor by a single vacci- nation of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70 [ J]. Hum Gene Ther, 2010,21 (1) :109-119.
7Chen IJ, Yen CF, Lin KJ, et al. Vaccination with OK-432 followed by TC-1 tumor lysate leads to significant antitu- mor effects [ J ]. Reprod Sci,2011,18 (7) :687-694.
8Quistian-Martinez D, Villatoro-Hernandez J, Loera-Arias M J, et al. Efficient secretion of a modified E7 protein from human papilloma virus type-16 by Lactococcus lactis[ J]. Lett Appl Microbiol,2010,51 (4) :383-387.
9Lee YS, Lee CW, Song M J, et al. Cell-mediated immune response to human papillomavirus 16 E7 peptide pools in patients with cervical neoplasia [ J ]. Acta Obstet Gynecol Scand,2011,90(12) : 1350-1356.
10Granadillo M, Vallespi MG, Batte A, et al. A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavir- us (HPV) type 16 E7 antigen generates potent immuno- logic and anti-tumor responses in mice [ J ]. Vaccine, 2011.29 (5) :920-930.
3Chang Y, Brewer N T, Rinas A C, et al. Evaluatin8 the Im- pact of Human Papillomavirus Vaccines[ J ]. Vaccine, 2009, 27(32):4355-4362.
4Ali S F, Ayub S, Manzoor N F, et al. Knowledge and Aware- ness about Cervical Cancer and Its Prevention among Interns and Nursing Staff in Tertiary Care Hospitals in Karachi, Pakistan[ J ]. PLoS One, 2010, 5(6): 11059.
5Ingledue K, Cottrell R, Bernard A. College Womens Knowl- edge Perceptions and Preventive Behaviors Regarding Hu- man Papillomavirus Infection and Cervical Cancer[ J ]. Am J Health Stud, 2004, 19(1):28-54.
6Hsu Y Y, Fetzer S J, Hsu K F, et al. Intention to Obtain Human Papilldma Virus Vaccination among Taiwan Residents Un- dergraduate Women[J ]. Sex Transm Dis, 2009, 36(11):686- 692.
7McCarey C, Pirek D, Tebeu P M, et al.Awareness of HPV and Cervical Cancer Prevention among Cameroonian Health- care Workers[ J ]. BMC Women' s Health, 2011,11(1):45.
8Denny-Smith T, Bairan A, Page M C. A Survey of Female Nursing Students' Knowledge, Health Beliefs, Perceptions of Risk, and Risk Behaviors Regarding Human Papillomavirus and Cervical Cancer[ J ]. JAANP, 2006, 18(2):62-69.
9Juntasopeepun P, Suwan N, Phianmongkhol Y, et al.Faetors Influencing Acceptance of Human Papillomavirus Vaccine among Young Female College Students in Thailand[ J ]. Int J Gynecol Obstet, 2012,118(3):247-250.
10Dunne E F, Unger E R, Sternberg M, et al. Prevalence of HPV Infection among Females in the United States[ J ]. JA- MA, 2007,297(8):813-819.
